Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serratus anterior block versus ketamine + dexmedetomidine infusion for post-thoracotomy pain
IRCT20250609066132N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bupivacaine, ketamine and dexmedetomidine in post-thoracotomy pain syndrome (PTPS) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started Jul 2025; status: completed.
02
Drugs
bupivacaineketaminedexmedetomidine
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on IRCT20250609066132N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250609066132N1.